Literature DB >> 7878851

Posttransplant B, non-A non-B, and cytomegalovirus hepatitis increase the risk of developing chronic rejection after liver transplantation.

O Bronsther1, R Mañez, S Kusne, W Irish, W Roland, A Jain, R Llull, A J Demetris, T E Starzl.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7878851      PMCID： PMC2975537     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  9 in total

1.  Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.

Authors:  J J Fung; S Todo; A Tzakis; A Demetris; A Jain; K Abu-Elmaged; M Alessiani; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

Review 2.  Non-A, non-B hepatitis.

Authors:  P J Scheuer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

3.  Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations.

Authors:  A J Demetris; S Todo; D H Van Thiel; J J Fung; Y Iwaki; G Sysyn; W Ming; J Trager; T E Starzl
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

4.  Non-A, non-B hepatitis: characterization of liver biopsy pathology.

Authors:  J H Lefkowitch; T F Apfelbaum
Journal:  J Clin Gastroenterol       Date:  1989-04       Impact factor: 3.062

5.  Chronic rejection after liver transplantation: a study of clinical, histopathological and immunological features.

Authors:  D K Freese; D C Snover; H L Sharp; C R Gross; S K Savick; W D Payne
Journal:  Hepatology       Date:  1991-05       Impact factor: 17.425

6.  Hepatitis C viral infection in liver transplant recipients.

Authors:  L D Ferrell; T L Wright; J Roberts; N Ascher; J Lake
Journal:  Hepatology       Date:  1992-10       Impact factor: 17.425

7.  Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients.

Authors:  A J Demetris; J J Fung; S Todo; J McCauley; A Jain; S Takaya; M Alessiani; K Abu-Elmagd; D H Van Thiel; T E Starzl
Journal:  Transplantation       Date:  1992-05       Impact factor: 4.939

8.  The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation.

Authors:  R Mañez; L T White; P Linden; S Kusne; M Martin; D Kramer; A J Demetris; D H Van Thiel; T E Starzl; R J Duquesnoy
Journal:  Transplantation       Date:  1993-05       Impact factor: 4.939

9.  Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation.

Authors:  J G O'Grady; G J Alexander; S Sutherland; P T Donaldson; F Harvey; B Portmann; R Y Calne; R Williams
Journal:  Lancet       Date:  1988-08-06       Impact factor: 79.321
  9 in total
  2 in total

1.  Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon.

Authors:  A Jain; A J Demetris; R Manez; A C Tsamanadas; D Van Thiel; J Rakela; T E Starzl; J J Fung
Journal:  Liver Transpl Surg       Date:  1998-05

2.  Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years.

Authors:  A Jain; A J Demetris; R Kashyap; K Blakomer; K Ruppert; A Khan; S Rohal; T E Starzl; J J Fung
Journal:  Liver Transpl       Date:  2001-07       Impact factor: 5.799
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.